{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:51:13Z","timestamp":1792821073625,"version":"4.5.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:p>This JAMA Insights Clinical Update discusses current recommendations regarding prevention of <jats:italic>Pneumocystis<\/jats:italic> pneumonia in patients who are immunocompromised.<\/jats:p>","DOI":"10.1001\/jama.2023.9844","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T15:32:25Z","timestamp":1687793545000},"page":"182","source":"Crossref","is-referenced-by-count":65,"title":["Prophylaxis Against <i>Pneumocystis jirovecii<\/i> Pneumonia in Adults"],"prefix":"10.1001","volume":"330","author":[{"given":"Shiwei","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Aitken","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"jit230012r1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/jof8111167","article-title":"The pathogenesis and diagnosis of pneumocystis jiroveci pneumonia.","volume":"8","author":"Apostolopoulou","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"jit230012r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2023.03.005","article-title":"Current concepts in the diagnosis and management of pneumocystis pneumonia in solid organ transplantation.","author":"Trubin","year":"2023","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"jit230012r4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel.","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"jit230012r5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology.","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"jit230012r6","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.v33.9","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"30","key":"jit230012r7","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"jit230012r8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","article-title":"Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented?","volume":"19","author":"Wolfe","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"jit230012r9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","article-title":"Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology: a position paper by the European Conference on Infections in Leukemia (ECIL).","volume":"33","author":"Maschmeyer","year":"2019","journal-title":"Leukemia"},{"issue":"suppl 2","key":"jit230012r10","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.cmi.2018.01.030","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies.","volume":"24","author":"Redelman-Sidi","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"jit230012r3","unstructured":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America; 2023."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2806750\/jama_zhou_2023_it_230012_1694198870.80806.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:09:04Z","timestamp":1694617744000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2806750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.9844","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,11]]}}}